Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models. (2016)

First Author: Sanchez-Martinez A
Attributed to:  Targeting glucocerebrosidase for disease-modifying treatments in Parkinson's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/srep31380

PubMed Identifier: 27539639

Publication URI: http://europepmc.org/abstract/MED/27539639

Type: Journal Article/Review

Volume: 6

Parent Publication: Scientific reports

ISSN: 2045-2322